Close Menu


The company also has applications in Maine, Maryland, and California for approval of its clinical lab.

Enzo has been awarded a license to provide clinical diagnostic services in Pennsylvania, which could help the eventual uptake of ColonSentry, a PCR-based colon cancer risk-stratification test manufactured by Canadian firm GeneNews and for which Enzo has exclusive distribution rights in New York and New Jersey.

Starting Aug. 1, Enzo Clinical Lab became part of Empire BCBS's network covering the metropolitan New York City area.

Siemens is asking a federal court to grant it rights to a patent covering nucleic acid amplification technology instead of Enzo.

US patents awarded to Gen-Probe, Enzo Life Sciences, Hitachi, Life Technologies, Hologic, and more.

The firm reported gains for both its life sciences and clinical labs businesses.

Siemens filed the rehearing request in response to a February ruling that Enzo's patent application covering its nucleic acid signal amplification technology predates and invalidates a patent owned by Siemens and relating to its branched DNA diagnostic systems.

Enzo said that a USPTO board had denied Siemens' request for a rehearing in proceedings that favored Enzo's patent on direct detection of nucleic acid.

A US Appeals Court overturned a lower court's decision in favor of Life Technologies predecessor firm Applera, clearing the way for it to pursue a claim for "substantial damages."

Cancer Genetics will incorporate Enzo's fluorescent dyes in its nucleic acid products for cancer research.


A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.